Considerations for introduction of a Rotavirus vaccine in Oman: Rotavirus disease and economic burden

Journal of Infectious Diseases

Volumn 200, Issue SUPPL. 1, 2009, Pages

  Al Awaidy, S A ^a   Bawikar, S ^a   Al Busaidy, S ^b   Baqiani, S ^b   Al Abedani, I ^a   Varghese, R ^b   Abdoan, H S ^c   Al Abdoon, H ^c   Bhatnagar, S ^d   Al Hasini, K S ^a   Mohan, P ^a   Shah, S ^a   Elamir, E ^a   Klena, J ^e   Ahmed, S F ^e   Teleb, N ^f   Parashar, U ^g   Patel, M M ^g  

^a Departments of Communicable Disease Surveillance and Control   (Oman)

^b Central Public Health Laboratory   (Oman)

^c SULTAN QABOOS UNIVERSITY   (Oman)

^d ROYAL HOSPITAL   (Oman)

^e US Naval Medical Research Unit No3   (Egypt)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ACUTE GASTROENTERITIS; ARTICLE; CHILD; CHILD HOSPITALIZATION; DISEASE SEVERITY; ECONOMIC EVALUATION; ENZYME IMMUNOASSAY; FECES ANALYSIS; FEMALE; HEALTH CARE; HEALTH CARE COST; HEALTH SURVEY; HOSPITAL CARE; HOSPITALIZED CHILD; HUMAN; INFANT; INFECTIOUS DIARRHEA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OMAN; OUTPATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLIC HOSPITAL; ROTAVIRUS; SEASONAL VARIATION; VIRUS IDENTIFICATION; VIRUS INFECTION; WORLD HEALTH ORGANIZATION;

CHILD, PRESCHOOL; COST OF ILLNESS; DIARRHEA; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; OMAN; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 72849145283     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/605339     Document Type: Article

References (16)

1. World Health Organization. Estimated rotavirus deaths for children under five years of age: 2004, 527 000. Geneva: World Health Organization, March 2006. Available at: http://www.who.int/immunization-monitoring/burden/rotavirus- estimates/en/. Accessed 16 June 2008.
2. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12:304-306
3. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22. (Pubitemid 43048947) (Pubitemid 43048947)
4. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33. (Pubitemid 43048948) (Pubitemid 43048948)
5. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 2007; 82:285-295
6. Glass RI, Parashar UD, Bresee JS, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006; 368:323-332 (Pubitemid 44067224) (Pubitemid 44067224)
7. Aithala G, Al Dhahry SH, Saha A, Elbualy MS. Epidemiological and clinical features of rotavirus gastroenteritis in Oman. J Trop Pediatr 1996; 42:54-57 (Pubitemid 26052760) (Pubitemid 26052760)
8. World Health Organization. Generic protocols for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children. Field test edition. Geneva:World Health Organization, 2002.
9. Gentsch JR, Glass RI,Woods P, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992; 30: 1365-1373
10. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565-572
11. World Health Organization. CHOosing Interventions that are Cost Effective (WHO-CHOICE). Estimates of unit costs for patient services for Oman. Available at: http://www.who.int/choice/country/omn/cost/en/index.html. Accessed 17 October 2008.
12. World Health Organization. CHOosing Interventions that are Cost Effective (WHO-CHOICE). An overview of the rationale, activities and goals of WHO-CHOICE. Available at: http://www.who.int/choice/description/adapt-estimates/en/. Accessed 14 September 2009.
13. Adam T, Evans DB, Murray CJ. Econometric estimation of countryspecific hospital costs. Cost Eff Resour Alloc 2003; 1:3. (Pubitemid 39111893) (Pubitemid 39111893)
14. Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Rev Panam Salud Publica 2007; 21:205-216 (Pubitemid 47147596) (Pubitemid 47147596)
15. Gentsch JR, Laird AR, Bielfelt B, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005; 192(Suppl 1): S146-59.
16. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005; 15:29-56. (Pubitemid 40070041)